The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion ...

Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” third quarter 2024 investor letter ...

Eli Lilly (NYSE: LLY) is the most valuable healthcare ... Novo Nordisk CFO Karsten Knudsen said in an interview that the company is encouraged by White House proposals that could support patients ...

Eli Lilly now ranks as the largest drugmaker in the world based on market cap ... Much of Lilly's recent dismal stock ...

Eli Lilly lost the momentum it had during the first half of the year. However, the company still has plenty of long-term ...

Eli Lilly and Company (NYSE: LLY) announced today that it has elected Jon Moeller as a new member of its board of directors ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 495.64% and currently trading at $787.50.The company has been around since 1876 and ...

The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

5. Eli Lilly is a top healthcare company with an extremely promising drug in tirzepatide in its portfolio, which has the potential to best the best-selling drug ever, with analysts estimating that ...